✦ LIBER ✦

The potential malaria vaccine `Quilimmune-M', containing the synthetic peptide antigen SPf66 and the adjuvant QS-21*,

Book ID: 120873933
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 1998
Weight: 109 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-199811610-00017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, tolerability and immunogenicity

Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21

✍ Oscar Kashala; Roberto Amador; Maria V. Valero; Alberto Moreno; Arnoldo Barbosa; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 206 KB

Synthesis of QS-21-Xylose: Establishment

Synthesis of QS-21-Xylose: Establishment of the Immunopotentiating Activity of Synthetic QS-21 Adjuvant with a Melanoma Vaccine

✍ Kai Deng; Michelle M. Adams; Payal Damani; Philip O. Livingston; Govind Ragupath 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 401 KB 👁 1 views

Synthesis of QS-21-Xylose: Establishment

Synthesis of QS-21-Xylose: Establishment of the Immunopotentiating Activity of Synthetic QS-21 Adjuvant with a Melanoma Vaccine

✍ Kai Deng; Michelle M. Adams; Payal Damani; Philip O. Livingston; Govind Ragupath 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 401 KB 👁 1 views